klisemfg Chapter 338.
Chapter 338.
……
"The ex-factory price in the international market is 5000 per box?"
"That's a factory price of over $700, which is a relatively normal price for medicine."
After hearing the news, Anna felt inexplicably relieved.
If Antai Pharmaceutical Group's drug prices were unified globally, it would be really difficult.
Because the price is too low, it will also affect other pharmaceutical companies, making it difficult for them to make huge profits.
For other pharmaceutical companies, they will lower drug prices, either because similar competing drugs appear, or because patents expire and a large number of copies appear, etc.
In addition, the price of the drug can only be lowered if the drug cannot be sold and there is no sales.
As for lowering drug prices for the sake of patients, that is simply impossible. They will not consider how much patients need the drug, but only whether the patients have money.
Life-saving drugs like Antai Pharmaceutical Group's lung cancer drug will only become sky-high priced drugs in the hands of these pharmaceutical companies.
Because this drug is bound to be a best-seller and there are no competing products, it can basically monopolize the entire market, and patients have no way to buy it.
As long as patients have money, they will definitely find a way to buy this medicine, because it is their hope of survival. Even if it is expensive, they will grit their teeth and buy it. If they don’t buy it, they can only wait to die.
So the price of this medicine will naturally be ridiculously expensive.
But Antai Pharmaceutical Group has launched a drug fee of 5000 yuan per month, which is even more outrageous.
This is also the reason why Anna is nervous. If there is really one price globally, Novartis will definitely be under great public pressure.
Most importantly, she also wanted to obtain the global agency rights for the lung cancer drug. If it was sold so cheaply, she really couldn't accept it.
After all, once the drug becomes so cheap all over the world, if Novartis becomes the agent for this drug, it will easily be besieged by other pharmaceutical companies, and ultimately lose more than it gains.
Fortunately, Antai Pharmaceutical Group did not do so.
The factory price of 2 is a relatively reasonable price.
It’s not outrageously expensive, but at least it’s not cheap either, which can give other pharmaceutical companies a little relief.
As for why the products are sold so cheaply in the Chinese market, it can be completely attributed to the Chinese Medical Insurance Bureau, which will give other pharmaceutical companies a reasonable explanation.
At that time, these pharmaceutical companies can also blame their respective countries for not having such a strong medical insurance as China, and completely shift the responsibility for sky-high drug prices. Then they can continue to sell high-priced drugs.
And at this time,
Anna's cell phone also rang. It was an international long-distance call.
When she saw the number clearly, Anna couldn't help but smile.
Luo Shiyun called.
The other party calling at this time means that the cooperation she has been thinking about should have come to fruition.
"Hello, Mr. Luo!"
"Regarding overseas agency, I certainly hope to cooperate with your company."
"As for Antai Pharmaceutical Group's offer, we can accept it. As for the profit, I think it should be fine."
After answering the call immediately,
Anna quickly confirmed that her guess was correct.
Luo Shiyun called at this time, indeed for overseas agency cooperation on the special medicine for lung cancer.
Anna has been eager for this agency cooperation.
After a brief thought, she readily agreed to the conditions proposed by Luo Shiyun.
The factory price of 2 is not excessive at all.
The only thing that made her hesitate was that the profit could only be around 10% and she couldn't increase the price too much.
This controlled Novartis's opportunity to make huge profits, which inevitably made her hesitate, but she finally agreed.
With a profit of about 10%, you can earn about 2000 yuan. Adding taxes and other fees, the actual retail price is estimated to be 25000 yuan.
However, the profit from Novartis's agency of this drug is secondary. The real purpose is to use it to enhance its own global influence. Therefore, it can be done even if the profit is low.
The most important thing is that the lung cancer specific drug is basically a best-selling drug that is guaranteed to make a profit. Even if the profit is low, it is a good business that is guaranteed to make a profit regardless of the market conditions. She has no reason to refuse.
As long as you can get this agency contract, you can make back the money elsewhere, and it will definitely not be a losing business.
Moreover, the lung cancer drug is so popular, if we can get the agency rights,
Then her status in Luohua will naturally rise, and she is very sincere in promoting this cooperation.
"It's done, it's finally done."
"My previous efforts were not in vain. I finally gained Chen Xuan's friendship."
"For this collaboration, I must lead the Novartis side. I can't let anyone else snatch it away."
After hanging up the phone, Anna couldn't help but get excited.
She felt that her sincerity during this period had finally paid off.
If she hadn't been actively showing goodwill, Chen Xuan wouldn't have thought of cooperating with her in the first place.
Lung cancer drugs are now in great demand. The fact that Novartis can directly obtain the agency rights can only mean that the previous cooperation and her goodwill played a role.
If it weren’t for the previous cooperation, I’m afraid we might not be able to compete with other pharmaceutical companies this time.
Anna was the first person to think of taking the lead in this project.
Novartis must take responsibility for itself so that it can make its own contribution and cannot let others reap the benefits for nothing.
She was also worried that someone else would mess things up.
"President, Pfizer is researching a pharmaceutical company."
"Based on the current information, Pfizer is very likely to acquire this pharmaceutical company."
"This is all the information about this pharmaceutical company. They've developed an anti-cancer drug, which is likely to become a blockbuster product in the future."
At this time, her assistant delivered an investigation report.
Pfizer and Novartis are also competitors, so they will naturally keep an eye on each other's actions.
If you don't monitor your competitors' every move, you might be foolishly unaware when they swallow you up.
After hearing this,
Anna's expression also became solemn, and she started reading the report immediately.
At this time, everyone knew that Pfizer would definitely make a big move.
The main reason is that the stock price has fallen too sharply, and the revenue of various businesses has also been declining. We must find a way to restore market confidence.
But if Pfizer wants to restore market confidence, it will inevitably affect the performance of other pharmaceutical companies. The market is so big that if someone takes a bigger bite, someone else will take a smaller bite.
Therefore, she also needs to pay great attention to Pfizer's series of actions.
“Is Pfizer so lucky?”
“This kind of project can find returns, which should be very ideal.”
"I just don't know how much it will cost Pfizer to get it, but as long as it can be done, it will certainly restore market confidence."
After reading the research report of the project,
Anna couldn't help but feel a little envious. This was indeed a very high-quality project.
If Pfizer successfully wins this project, it may be able to restore market confidence with this project, and the stock price will probably rise again soon, or at least will not fall again.
The most important thing is that the success rate of this anti-cancer drug project has been very high to date. If it is basically completed, the possibility of failure will be very small.
As for how big the market for this anti-cancer drug will be, it depends on how effective the drug itself is and how Pfizer operates it.
……